MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00464-020-08162-7

Медицинская библиотека · Surgical endoscopy · 2020

Evaluating the advantages of treating acute cholecystitis by following the Tokyo Guidelines 2018 (TG18): a study emphasizing clinical outcomes and medical expenditures.

Lin Yu-Ning, Wu Yu-Tung, Fu Chih-Yuan, Liao Chien-Hung, Cheng Chi-Tung, Wang Shang-Yu, Lin Being-Chuan, Hsu Yu-Pao, Kang Shih-Ching, Liu Erh-Hao, Kuo I-Ming, Ou Yang Chun-Hsiang, Yang Shang-Ju, Huang Jen-Fu, Hsu Chih-Po, Hsieh Feng-Jen, Liao Chien-An, Kuo Ling-Wei, Tee Yu-San, Hsieh Chi-Hsun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Acute cholecystitis (AC) is a common surgical emergency. The Tokyo Guidelines 2018 (TG18) provides a reliable algorithm for the treatment of AC patients to achieve optimal outcomes. However, the economic benefits have not been validated. We hypothesize that good outcomes and cost savings can both be achieved if patients are treated according to the TG18.

METHOD: This retrospective study included 275 patients who underwent cholecystectomy in a 15-month span. Patients were divided into three groups (group 1: mild AC; group 2: moderate AC with American Society of Anesthesiologists (ASA) physical status class ≤ 2 and Charlson Comorbidity Index (CCI) score ≤ 5; and group 3: moderate AC with ASA class ≥ 3, CCI score ≥ 6, or severe AC). Each group was further divided into two subgroups according to management (followed or deviated from the TG18). Patient demographics, clinical outcomes, and hospital costs were compared.

RESULTS

For group 1 patients, 77 (81%) were treated according to the TG18 and had a significantly higher successful laparoscopic cholecystectomy (LC) rate (100%), lower hospital cost ($1896 vs $2388), and shorter hospital stay (2.9 vs 8 days) than those whose treatment deviated from the TG18. For group 2 patients, 50 (67%) were treated according to the TG18 and had a significantly lower hospital cost ($1926 vs $2856), shorter hospital stay (3.9 vs 9.9 days), and lower complication rate (0% vs 12.5%). For group 3 patients, 62 (58%) were treated according to the TG18 and had a significantly lower intensive care unit (ICU) admission rate (9.7% vs 25%), but a longer hospital stay (12.6 vs 7.8 days). However, their hospital costs were similar. Early LC in group 3 patients did not have economic benefits over gallbladder drainage and delayed LC.

CONCLUSION

The TG18 are the state-of-the-art guidelines for the treatment of AC, achieving both satisfactory outcomes and cost-effectiveness.

Для цитирования: Lin Yu-Ning, Wu Yu-Tung, Fu Chih-Yuan, Liao Chien-Hung, Cheng Chi-Tung, Wang Shang-Yu, Lin Being-Chuan, Hsu Yu-Pao, Kang Shih-Ching, Liu Erh-Hao, Kuo I-Ming, Ou Yang Chun-Hsiang, Yang Shang-Ju, Huang Jen-Fu, Hsu Chih-Po, Hsieh Feng-Jen, Liao Chien-An, Kuo Ling-Wei, Tee Yu-San, Hsieh Chi-Hsun. Evaluating the advantages of treating acute cholecystitis by following the Tokyo Guidelines 2018 (TG18): a study emphasizing clinical outcomes and medical expenditures.. Surgical endoscopy. 2020. DOI: 10.1007/s00464-020-08162-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.